Back to Search
FRANCISCO CERVANTES, M.D.
Pediatrics Physician
NPI: 1730135237Individual
Specialties, Licenses & Credentials
Neonatal-Perinatal Medicine Physician
Pediatrics — Neonatal-Perinatal Medicine
Code: 2080N0001X
H5507(TX)
Pediatrics PhysicianPrimary
Pediatrics
Code: 208000000X
H5507(TX)
Research & Publications (20)
New prognostic scoring system for primary myelofibrosis based on a study of the International Working Group for Myelofibrosis Research and Treatment.
PMID 18988864·Blood·2009
4-observational
Kinetic limitations during the simultaneous removal of p-cresol and sulfide in a denitrifying process.
PMID 19672641·J Ind Microbiol Biotechnol·2009
8-other
Pomalidomide is active in the treatment of anemia associated with myelofibrosis.
PMID 19652059·J Clin Oncol·2009
3-trial
Survival in young patients with intermediate- / high-risk myelofibrosis: estimates derived from databases for non transplant patients.
PMID 19123461·Am J Hematol·2009
4-observational
Effects of different quinoid redox mediators on the simultaneous removal of p-cresol and sulphide in a denitrifying process.
PMID 19474488·Water Sci Technol·2009
8-other
Epigenetic down-regulation of BIM expression is associated with reduced optimal responses to imatinib treatment in chronic myeloid leukaemia.
PMID 19403302·Eur J Cancer·2009
8-other
Platelet turnover, coagulation factors, and soluble markers of platelet and endothelial activation in essential thrombocythemia: relationship with thrombosis occurrence and JAK2 V617F allele burden.
PMID 19105233·Am J Hematol·2009
8-other
Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment.
PMID 17728787·Leukemia·2008
8-other
Dasatinib induces durable cytogenetic responses in patients with chronic myelogenous leukemia in chronic phase with resistance or intolerance to imatinib.
PMID 18401416·Leukemia·2008
8-other
Repetitive DNA hypomethylation in the advanced phase of chronic myeloid leukemia.
PMID 17765966·Leuk Res·2008
8-other
Effect of nitrate on the reduction of Reactive Red 2 by mesophilic anaerobic sludge.
PMID 18441434·Water Sci Technol·2008
8-other
Increased platelet, leukocyte, and coagulation activation in primary myelofibrosis.
PMID 17899078·Ann Hematol·2008
8-other
Life expectancy and prognostic factors in the classic BCR/ABL-negative myeloproliferative disorders.
PMID 18385755·Leukemia·2008
6-review
Impact of prior imatinib mesylate on the outcome of hematopoietic cell transplantation for chronic myeloid leukemia.
PMID 18664621·Blood·2008
8-other
The impact of JAK2 and MPL mutations on diagnosis and prognosis of splanchnic vein thrombosis: a report on 241 cases.
PMID 18250227·Blood·2008
8-other
Contribution of quinone-reducing microorganisms to the anaerobic biodegradation of organic compounds under different redox conditions.
PMID 17534721·Biodegradation·2008
8-other
Biogenic sulphide plays a major role on the riboflavin-mediated decolourisation of azo dyes under sulphate-reducing conditions.
PMID 17350080·Chemosphere·2007
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 3507 JAIME ZAPATA MEMORIAL HWY STE 5
LAREDO, TX 78043 - Phone
- (956) 726-9252
Quick Facts
- NPI
- 1730135237
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile